EUVIMEDEUVIMED entdecken
Open Access

The electrophysiologic effects of KCNQ1 extend beyond expression of I Ks: evidence from genetic and pharmacologic block

Yuko Wada iD, Lili Wang, Lynn D Hall, Tao Yang, Laura L Short, Joseph F Solus, Andrew M Glazer, Dan M Roden iD

Cardiovascular Research · 2024

DOI: 10.1093/cvr/cvae042 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Research, 2024. Verfasst von Yuko Wada und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Vanderbilt University Medical Center, 2215B Garland Ave, 1285 MRBIV, Nashville, TN 37232, USA. Hauptthemen laut MEDLINE: Action Potentials, Induced Pluripotent Stem Cells, Jervell-Lange Nielsen Syndrome, KCNQ1 Potassium Channel. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NIDDK NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

While variants in KCNQ1 are the commonest cause of the congenital long QT syndrome, we and others find only a small IKs in cardiomyocytes from human-induced pluripotent stem cells (iPSC-CMs) or human ventricular myocytes. Methods and results We studied population control iPSC-CMs and iPSC-CMs from a patient with Jervell and Lange-Nielsen (JLN) syndrome due to compound heterozygous loss-of-function (LOF) KCNQ1 variants. We compared the effects of pharmacologic IKs block to those of genetic KCNQ1 ablation, using JLN cells, cells homozygous for the KCNQ1 LOF allele G643S, or siRNAs reducing KCNQ1 expression. We also studied the effects of two blockers of IKr, the other major cardiac repolarizing current, in the setting of pharmacologic or genetic ablation of KCNQ1: moxifloxacin, associated with a very low risk of drug-induced long QT, and dofetilide, a high-risk drug. In control cells, a small IKs was readily recorded but the pharmacologic IKs block produced no change in action potential duration at 90% repolarization (APD90). In contrast, in cells with genetic ablation of KCNQ1 (JLN), baseline APD90 was markedly prolonged compared with control cells (469 ± 20 vs. 310 ± 16 ms). JLN cells displayed increased sensitivity to acute IKr block: the concentration (μM) of moxifloxacin required to prolong APD90 100 msec was 237.4 [median, interquartile range (IQR) 100.6–391.6, n = 7] in population cells vs. 23.7 (17.3–28.7, n = 11) in JLN cells. In control cells, chronic moxifloxacin exposure (300 μM) mildly prolonged APD90 (10%) and increased IKs, while chronic exposure to dofetilide (5 nM) produced greater prolongation (67%) and no increase in IKs. However, in the siRNA-treated cells, moxifloxacin did not increase IKs and markedly prolonged APD90.

Conclusion

Our data strongly suggest that KCNQ1 expression modulates baseline cardiac repolarization, and the response to IKr block, through mechanisms beyond simply generating IKs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Action PotentialsInduced Pluripotent Stem CellsJervell-Lange Nielsen SyndromeKCNQ1 Potassium ChannelMoxifloxacinMyocytes, CardiacHumansFluoroquinolonesPhenethylaminesPotassium Channel BlockersSulfonamides

Stichwörter der Autor:innen

KCNQ1IKrIKsLong QTRepolarization reserve

Substanzen

dofetilideFluoroquinolonesKCNQ1 Potassium ChannelKCNQ1 protein, humanMoxifloxacinPhenethylaminesPotassium Channel BlockersSulfonamides

Autor:innen und Institutionen

  • Department of Medicine, Vanderbilt University Medical Center, 2215B Garland Ave, 1285 MRBIV, Nashville, TN 37232, USA.
  • Departments of Medicine, Pharmacology, and Biomedical Informatics, Vanderbilt University Medical Center, 2215B Garland Ave, 1285 MRBIV, Nashville, TN 37232, USA.

ORCID-Profile: Yuko Wada, Dan M Roden

Förderung

  • NIH HHS
  • NIDDK NIH HHS
  • NCI NIH HHS
  • NHLBI NIH HHS
  • NHGRI NIH HHS
  • American Heart Association
  • NIGMS NIH HHS
  • Heart Rhythm Society

Zitieren

APA

Wada, Y., Wang, L., Hall, L. D., Yang, T., Short, L. L., Solus, J. F., Glazer, A. M., & Roden, D. M. (2024). The electrophysiologic effects of KCNQ1 extend beyond expression of I Ks: evidence from genetic and pharmacologic block. Cardiovascular Research. https://doi.org/10.1093/cvr/cvae042

Vancouver

Wada Y, Wang L, Hall LD, Yang T, Short LL, Solus JF, et al. The electrophysiologic effects of KCNQ1 extend beyond expression of I Ks: evidence from genetic and pharmacologic block. Cardiovascular Research. 2024. doi:10.1093/cvr/cvae042

BibTeX
@article{Wada2024,
  author = {Wada, Yuko and Wang, Lili and Hall, Lynn D and Yang, Tao and Short, Laura L and Solus, Joseph F and Glazer, Andrew M and Roden, Dan M},
  title = {The electrophysiologic effects of KCNQ1 extend beyond expression of I Ks: evidence from genetic and pharmacologic block},
  journal = {Cardiovascular Research},
  year = {2024},
  doi = {10.1093/cvr/cvae042}
}
Kostenlos starten →